This is a self-correcting exercise. Click on the letter (A, B, or C) or "Quiz Yourself" for a pop-up box with the response.
Note: If you do not see a pop-up box, check your pop-up blocker settings in your browser. If that is not the problem, try closing the previous pop-up box or check to see if the pop-up box is behind your browser window. If you still do not see the pop-up box, you may need to update your browser.
This is a self-correcting exercise. Click on the letter (A, B, or C) or "Quiz Yourself" for a pop-up box with the response.
Note: If you do not see a pop-up box, check your pop-up blocker settings in your browser. If that is not the problem, try closing the previous pop-up box or check to see if the pop-up box is behind your browser window. If you still do not see the pop-up box, you may need to update your browser.
Start with the patient -- a clinical problem or question arises from the care of the patient
Choose the BEST clinical question:
What is the best treatment for diarrhea?
In patients taking antibiotics, are probiotics helpful in preventing diarrhea?
Do probiotics prevent diarrhea in the elderly hospitalized patient?
Choose the best PubMed search strategy to address the clinical question.
Search: diarrhea AND best treatment Limited to Free Full Text
Search: diarrhea AND probiotics AND elderly AND female AND adult Limited to English
Search: antibiotics AND diarrhea AND probiotics Limited to randomized controlled trial
Read the following article and determine if it meets the validity criteria. (Click on title to access free full text)
Beausoleil M. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007 Nov;21(11):732-6. PMCID: PMC2658588 PMID: 18026577
ABSTRACT:
BACKGROUND: Antibiotic-associated diarrhea is an important problem in hospitalized patients. The use of probiotics is gaining interest in the scientific community as a potential measure to prevent this complication. The main objective of the present study was to assess the efficacy and safety of a fermented milk combining Lactobacillus acidophilus and Lactobacillus casei that is widely available in Canada, in the prevention of antibiotic-associated diarrhea. METHODS: In this double-blind, randomized study, hospitalized patients were randomly assigned to receive either a lactobacilli-fermented milk or a placebo on a daily basis.
RESULTS: Among 89 randomized patients, antibiotic-associated diarrhea occurred in seven of 44 patients (15.9%) in the lactobacilli group and in 16 of 45 patients (35.6%) in the placebo group (OR 0.34, 95% CI 0.125 to 0.944; P=0.05). The median hospitalization duration was eight days in the lactobacilli group, compared with 10 days in the placebo group (P=0.09). Overall, the lactobacilli-fermented milk was well tolerated. CONCLUSION: The daily administration of a lactobacilli-fermented milk was safe and effective in the prevention of antibiotic-associated diarrhea in hospitalized patients.
Are the results valid?
You will need to read the methodology section of the article to address the validity questions. Evaluating the medical literature is a complex undertaking. You will find that the answers to the questions of validity may not always be clearly stated in the article and that you may have to use your own judgment about the importance and significance of each question.
Randomization: Were patients randomized?
Concealed allocation: Was group allocation concealed?
Baseline characteristics: Were patients in the study groups similar with respect to known prognostic variables?
Blinding: To what extent was the study blinded?
Follow-up: Was follow-up complete?
Intention to Treat: Were patients analyzed in the groups to which they were first allocated?
Equal treatment: Aside from the experimental intervention, were the groups treated equally?
What are the results & how can I apply them to patient care?
Results: Among 89 randomized patients, antibiotic-associated diarrhea occurred in seven of 44 patients (15.9%) in the lactobacilli group and in 16 of 45 patients (35.6%) in the placebo group (OR 0.34, 95% CI 0.125 to 0.944; P=0.05). The median hospitalization duration was eight days in the lactobacilli group, compared with 10 days in the placebo group (P=0.09). Overall, the lactobacilli-fermented milk was well tolerated.
Outcome Present ADD occurrence |
Outcome NOT present ADD no occurrence |
|
lactobacilli group | 7 | 37 |
placebo group | 16 | 29 |
Experimental (lactobacilli) Event Rate = 7 / 44 = 15.9%
Control (placebo) Event Rate = 16 / 45 = 35.5%
Absolute Risk Reduction = 35.5% - 15.9% = 19.6%
Relative Risk reduction = 19.6% / 35.5% = 53.5%
Number Needed-to-Treat = 1/ 19.6% = 5
The results of Beausoleil and colleagues are consistent with those of a recent systematic review showing that probiotics reduce the frequency of antibiotic-associated diarrhea and accelerate resolution of C. difficile–associated colitis. The study was underpowered to demonstrate an effect on more clinically important outcomes. The intervention is simple, rational, and presumably relatively inexpensive. Thus, it could be reasoned that it should be implemented more widely without further study. On the other hand, there have been isolated reports of systemic infection with organisms used as probiotics. Moreover, in light of the potential importance of minimizing the adverse effects of systemic antibiotics in hospitalized patients, further studies should be powered to probe the effects of probiotics on rates of acquisition of nosocomial infections (with both typical nosocomial pathogens and the probiotic itself) and on clinically important outcomes, such as length of stay and nutritional status. In addition, further work to determine which microbial species exert optimal probiotic effects will aid in defining a role for probiotics in routine clinical practice. [ACP Journal Club 15 July 2008 - Volume 149, Number 1)
Questions to consider before applying the results of a study to your patient:
APPLY: talk with the patient
Return to the patient -- integrate that evidence with clinical expertise, patient preferences and apply it to practice
Think about your patient, her goals, your treatment recommendation for her, the cost and adverse effects of probiotics, and help her decide whether to start taking the probiotics.
|
|